Abstract
Positron emission tomography (PET) with 68Ga-labeled peptides is a promising option in the imaging of tumors expressing peptide-binding receptors. PET scanning is non-invasive but involves internal exposure to ionizing radiation which could subsequently generate biological effects, particularly on targeted cells. The aim of the present study was to investigate the potential biological effects of 68Ga-labeled peptides on different targeted tumor cells in vitro. Human U87MG and HT-29 cells and murine AR42J and B16F10 cells were incubated with the following 68Ga-labeled peptides: 68Ga-NODAGA-c(RGDfK), 68Ga-DOTA-c(RGDfK), 68Ga-NOTA-TATE, 68Ga-DOTA-NOC, 68Ga-NODAGA-NOC, or 68Ga-NOTA-(Cys-39)-Exendin-4. Cell cycle analysis and annexin V/PI assay for apoptosis were performed by flow cytometry. Oxidative stress was evaluated by spectrophotometric measuring the level of reactive oxygen species (ROS) and total thiols. After incubation with 37 kBq/ml (1 µCi/ml) 68Ga-labeled peptides, generally observed an increase of apoptosis and cell cycle arrest, especially in G2/M. Furthermore, the increased ROS generation was mostly correlated with apoptosis. Our data demonstrated the ability of 68Ga-labeled peptides to exert significant inhibitory effects on tumor cell lines, through the cycle dysregulation and induction of apoptosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. https://doi.org/10.1155/2014/360438
Bump EA, Brown JM (1990) Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacol Ther 47(1):117–136. https://doi.org/10.1016/0163-7258(90)90048-7
Cheng Z, Wu Y, Xiong Z, Sam Gambhir S, Xiaoyuan C (2005) Near-infrared fluorescent RGD peptides for optical imaging of integrin αvβ3 expression in living. Mice Bioconjugate Chem 16(6):1433–1441. https://doi.org/10.1021/bc0501698
Chilug LE, Leonte RA, Barbinta Patrascu ME, Ion AC, Tuta CS, Raicu A, Manda G, Niculae D (2017) In vitro binding kinetics study of gold nanoparticles functionalized with 68Ga-DOTA conjugated peptides. J Radioanal Nucl Chem 311(2):1485–1493. https://doi.org/10.1007/s10967-016-5075-z
Cowden Dahl KD, Robertson SE, Weaver VM, Celeste Simon M (2005) Hypoxia-inducible factor regulates v3 integrin cell surface expression. Mol Biol Cell 16:1901–1912
Davies KJ (1999) The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48(1):41–47. https://doi.org/10.1080/713803463
Delamarre E, Taboubi S, Mathieu S, Bérenguer C, Rigot V, Lissitzky JC, Figarella-Branger D, Ouafik L, Luis J (2009) Expression of integrin α6β1 enhances tumorigenesis in glioma cells. Am J Pathol 175(2):844–855. https://doi.org/10.2353/ajpath.2009.080920
Domcke S, Sinha R, Levine DA, Sander C, Schultz N (2013) Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 4:2126. https://doi.org/10.1038/ncomms3126
Domnanich KA, Müller C, Farkas R, Schmid RM, Ponsard B, Schibli R, Türler A, van der Meulen NP (2016) 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharm Chem 1:8. https://doi.org/10.1186/s41181-016-0013-5
Fani M, Maecke HR, Okarvi SM (2012) Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics 2(5):481–501. https://doi.org/10.7150/thno.4024
Goodman SL, Grote HJ, Wilm C (2012) Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors. Biol Open 1(4):329–340. https://doi.org/10.1242/bio.2012364
Gutteridge JMC (1995) Lipid proxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41(12):1819–1828. http://clinchem.aaccjnls.org/content/41/12/1819.long
Halliwell B (2003) Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett 540(1–3):3–6. https://doi.org/10.1016/S0014-5793(03)00235-7
Iliakis G, Wang Y, Guan J, Wang H (2003) DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22:5834–5847. https://doi.org/10.1038/sj.onc.1206682
Kiaris H, Schally AV, Nagy A, Sun B, Szepeshazi K, Halmos G (2000) Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-2381. Clin Cancer Res 6:709–717
Körner M, Stöckli M, Waser B, Reubi JC (2007) GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48(5):736–743. https://doi.org/10.2967/jnumed.106.038679
Liu S (2009) Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem 20(12):2199–2213. https://doi.org/10.1021/bc900167c
Lungu V, Niculae D, Panait M, Chiper D (2007) 177Lu-DOTA-Tyr3-TATE radiotherapy experiments using animal models. Flow cytometric analysis in evaluation of therapeutic effect. J Labelled Compound Radiopharm 50:489–491
Maecke HR, Hofmann M, Haberkorn U (2005) (68)Ga-labeled peptides in tumor imaging. J Nucl Med 46(1):172–178. http://jnm.snmjournals.org/content/46/1_suppl/172S.long
Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192(1):1–15. https://doi.org/10.1002/jcp.10119
Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G, Spaziante R, Florio T, Schettini G (2004) The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. J Biol Chem 279(28):29004–29012. https://doi.org/10.1074/jbc.M403573200
Nguyen PK, Wu JC (2011) Radiation exposure from imaging tests: is there an increased cancer risk? Expert Rev Cardiovasc Ther 9(2):177–183. https://doi.org/10.1586/erc.10.184
Niculae D, Niculae A (2015) Qualification of 68Ge/68Ga generators: a comparison of organic matrix and tin oxide based generators. J Nucl Med 56(3):1055. http://jnm.snmjournals.org/content/56/supplement_3 /1055
Niculae D, Puicea FD, Esanu I, Negoita V, Savu D (2013) Development of NOTA/DOTA cyclo-RGD dimers labelled with Ga-68 for cancer diagnosis and therapy follow-up. J Nucl Med 54(2):1131. http://jnm.snmjournals.org/content/54/supplement_2/1131
Niculae D, Mihon M, Leonte R, Silisteanu A (2015) Development of radiopharmaceuticals to target neurotensin receptors based on 68Ga and 177Lu. J Nucl Med 56(3):1152. http://jnm.snmjournals.org/content/56/ supplement_3/1152
Notni J, Pohle K, Wester HJ (2012) Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. EJNMMI Res. https://doi.org/10.1186/2191-219X-2-28
Oliveira EA, Faintuch BL, Nunez EGF, Morob AM, Nanda PK, Smith CJ (2012) Radiotracers for different angiogenesis receptors in a melanoma model. Melanoma Res 22:45–53. https://doi.org/10.1097/CMR.0b013e32834e6a7e
Patrascu I, Niculae D, Lungu V, Ursu I, Iliescu M, Tuta C, Antohe A (2011) The purification and the quality control of 68 Ga eluates from 68Ge/68 Ga generator. Rom Rep Phys 63(4):988–996. https://www.researchgate.net/publication/228441825
Pickarski M, Gleason A, Bednar B, Duong LT (2015) Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis. Oncol Rep 33(6):2737–2745. https://doi.org/10.3892/or.2015.3910
Reubi J, Maecke HR (2008) Peptide-based probes for cancer imaging. J Nucl Med 49:1735–1738. https://doi.org/10.2967/jnumed.108.053041
Sanchez-Crespo A (2013) Comparison of gallium-68 and fluorine-18 imaging characteristics in positron emission tomography. Appl Radiat Isotopes 76:55–62. https://doi.org/10.1016/2012.06.034
Shapiro GI, Harper JW (1999) Anticancer drug targets: cell cycle and checkpoint control. J Clin Investig 104:1645–1653. https://doi.org/10.1172/JCI9054
Sharma P, Singh H, Bal C, Kumar R (2014) PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues. An overview and single institutional experience from India. Indian J Nucl Med 29(1):2–12. https://doi.org/10.4103/0972-3919.125760
Sun L, Luo J, Mackey LV, Morris LM, Franko-Tobin LG, LePage KT, Coy DH (2011) Investigation of cancer cell lines for peptide receptor-targeted drug development. J Drug Target 19(8):719–730. https://doi.org/10.3109/1061186X.2011.558089
Varanda E, Tavares DC (1998) Radioprotection: mechanisms and radioprotective agents including honeybee venom. J Venom Anim Toxins. https://doi.org/10.1590/S0104-79301998000100002
Volante M, Cassenti A, Rapa I, Righi L, Papotti M (2015) Somatostatin receptors in malignancies and other pathologies. In: Hubalewska-Dydejczyk A, Signore A, de Jong M, Dierckx RA, Buscombe J, Van de Wiele C (eds) Somatostatin analogues: from research to clinical practice. Wiley, Hoboken. https://doi.org/10.1002/9781119031659 (Print ISBN: 9781118521533 Online ISBN: 9781119031659)
Wang YR, Xu Y, Jiang ZZ, Guerram M, Wang B, Zhu X, Zhang LY (2015) Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in SGC-7901 cells and inhibits tumor growth in vivo. Molecules 20(1):1661–1675. https://doi.org/10.3390/molecules20011661
Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W, Yuan CS (2013) Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol 43(1):289–296. https://doi.org/10.3892/ijo.2013.1946
Zheng Y, Ji S, Czerwinski A, Valenzuela F, Pennington M, Liu S (2014) FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues. Bioconjug Chem 25(11):1925–1941. https://doi.org/10.1021/bc500452y
Zhou J, Montrose-Rafizadeh C, Janczewski AM, Pineyro MA, Sollott SJ, Wang Y, Egan JM (1999a) Glucagon-like peptide-1 does not mediate amylase release from AR42J cells. J Cell Physiol 181(3):470–478. https://doi.org/10.1002/(SICI)1097-4652(199912)181:3%3C470::AID-JCP11%3E3.0.CO;2-P
Zhou J, Wang X, Pineyro MA, Egan JM (1999b) Glucagon like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulinproducing cells. Diabetes 48:2358–2366
Funding
This study was funded through the National Research Program Partnerships in Priority Areas by UEFISCDI (Project Number 228/2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Panait, M.E., Chilug, L., Negoita, V. et al. Biological Effects Induced by 68Ga-Conjugated Peptides in Human and Rodent Tumor Cell Lines. Int J Pept Res Ther 25, 979–987 (2019). https://doi.org/10.1007/s10989-018-9745-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-018-9745-2